Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Jun 21, 2023 £190.00 £200.00 £180.00 £181.00 99 270
Jun 20, 2023 £200.10 £205.00 £192.09 £193.80 151 258
Jun 19, 2023 £210.00 £210.00 £200.48 £206.00 72 490
Jun 16, 2023 £208.35 £229.25 £208.35 £219.00 74 223
Jun 15, 2023 £199.99 £209.00 £196.74 £207.00 35 714
Jun 14, 2023 £193.00 £199.80 £193.00 £199.00 12 341
Jun 13, 2023 £190.90 £198.10 £190.74 £194.00 14 404
Jun 12, 2023 £191.80 £194.66 £190.00 £190.00 17 046
Jun 09, 2023 £195.90 £195.90 £190.80 £190.80 20 791
Jun 08, 2023 £195.00 £199.80 £192.20 £195.50 106 471
Jun 07, 2023 £198.56 £208.23 £197.45 £200.00 15 284
Jun 06, 2023 £198.17 £200.84 £196.00 £200.00 39 809
Jun 05, 2023 £200.00 £203.50 £198.40 £203.50 30 513
Jun 02, 2023 £202.68 £203.00 £197.93 £202.00 7 318
Jun 01, 2023 £201.92 £209.50 £193.21 £199.30 28 729
May 31, 2023 £197.27 £206.08 £193.20 £193.20 20 537
May 30, 2023 £208.50 £210.50 £198.00 £198.00 58 348
May 26, 2023 £215.00 £217.85 £208.00 £213.00 20 497
May 25, 2023 £209.20 £219.50 £203.46 £205.50 12 770
May 24, 2023 £212.59 £219.15 £205.60 £208.00 17 997
May 23, 2023 £218.85 £219.50 £213.65 £216.50 4 941
May 22, 2023 £213.88 £218.00 £213.00 £218.00 16 464
May 19, 2023 £211.55 £216.60 £201.49 £206.00 80 452
May 18, 2023 £213.49 £218.87 £211.50 £218.00 50 226
May 17, 2023 £223.45 £223.45 £223.45 £223.45 0
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT